Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 361

1.

Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.

McElroy SL, Suppes T, Frye MA, Altshuler LL, Stanford K, Martens B, Leverich GS, Post RM, Keck PE Jr.

J Affect Disord. 2007 Aug;101(1-3):275-81. Epub 2007 Jan 16.

PMID:
17229469
[PubMed - indexed for MEDLINE]
2.

Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.

Mazza M, Squillacioti MR, Pecora RD, Janiri L, Bria P.

Expert Opin Pharmacother. 2008 Dec;9(18):3145-9. doi: 10.1517/14656560802504490 .

PMID:
19040335
[PubMed - indexed for MEDLINE]
3.

A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.

Dunn RT, Stan VA, Chriki LS, Filkowski MM, Ghaemi SN.

J Affect Disord. 2008 Sep;110(1-2):70-4. doi: 10.1016/j.jad.2008.01.004. Epub 2008 Feb 12.

PMID:
18272230
[PubMed - indexed for MEDLINE]
4.

Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.

Keck PE Jr, Calabrese JR, McIntyre RS, McQuade RD, Carson WH, Eudicone JM, Carlson BX, Marcus RN, Sanchez R; Aripiprazole Study Group.

J Clin Psychiatry. 2007 Oct;68(10):1480-91.

PMID:
17960961
[PubMed - indexed for MEDLINE]
5.

Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.

Vieta E, T'joen C, McQuade RD, Carson WH Jr, Marcus RN, Sanchez R, Owen R, Nameche L.

Am J Psychiatry. 2008 Oct;165(10):1316-25. doi: 10.1176/appi.ajp.2008.07101560. Epub 2008 Apr 1.

PMID:
18381903
[PubMed - indexed for MEDLINE]
6.

Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.

Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN.

Curr Med Res Opin. 2010 Jun;26(6):1485-96. doi: 10.1185/03007991003779380.

PMID:
20429835
[PubMed - indexed for MEDLINE]
7.

A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.

Keck PE Jr, Calabrese JR, McQuade RD, Carson WH, Carlson BX, Rollin LM, Marcus RN, Sanchez R; Aripiprazole Study Group.

J Clin Psychiatry. 2006 Apr;67(4):626-37.

PMID:
16669728
[PubMed - indexed for MEDLINE]
8.

Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline.

Sachs GS, Gaulin BD, Gutierrez-Esteinou R, McQuade RD, Pikalov A 3rd, Pultz JA, Sanchez R, Marcus RN, Crandall DT.

J Clin Psychiatry. 2007 Sep;68(9):1377-83.

PMID:
17915976
[PubMed - indexed for MEDLINE]
9.

Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.

Keck PE, Orsulak PJ, Cutler AJ, Sanchez R, Torbeyns A, Marcus RN, McQuade RD, Carson WH; CN138-135 Study Group.

J Affect Disord. 2009 Jan;112(1-3):36-49. doi: 10.1016/j.jad.2008.05.014. Epub 2008 Oct 2.

PMID:
18835043
[PubMed - indexed for MEDLINE]
10.

Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial.

Sajatovic M, Coconcea N, Ignacio RV, Blow FC, Hays RW, Cassidy KA, Meyer WJ.

J Clin Psychiatry. 2008 Jan;69(1):41-6.

PMID:
18312036
[PubMed - indexed for MEDLINE]
11.

Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.

Suppes T, Eudicone J, McQuade R, Pikalov A 3rd, Carlson B.

J Affect Disord. 2008 Apr;107(1-3):145-54. Epub 2007 Sep 27.

PMID:
17904226
[PubMed - indexed for MEDLINE]
12.

Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.

van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

J Clin Psychiatry. 2009 Feb;70(2):223-31. Epub 2008 Dec 30.

PMID:
19200421
[PubMed - indexed for MEDLINE]
13.

Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients.

Mazza M, Squillacioti MR, Pecora RD, Janiri L, Bria P.

Psychiatry Res. 2009 Jan 30;165(1-2):193-6. doi: 10.1016/j.psychres.2008.05.003. Epub 2008 Oct 30.

PMID:
18973955
[PubMed - indexed for MEDLINE]
14.

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.

Keck PE Jr, Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, Ingenito G; Aripiprazole Study Group.

Am J Psychiatry. 2003 Sep;160(9):1651-8.

PMID:
12944341
[PubMed - indexed for MEDLINE]
15.

Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.

Thase ME, Jonas A, Khan A, Bowden CL, Wu X, McQuade RD, Carson WH, Marcus RN, Owen R.

J Clin Psychopharmacol. 2008 Feb;28(1):13-20. doi: 10.1097/jcp.0b013e3181618eb4. Erratum in: J Clin Psychopharmacol. 2009 Feb;29(1):38.

PMID:
18204335
[PubMed - indexed for MEDLINE]
16.

An open-label study of aripiprazole in children with a bipolar disorder.

Findling RL, McNamara NK, Youngstrom EA, Stansbrey RJ, Frazier TW, Lingler J, Otto BD, Demeter CA, Rowles BM, Calabrese JR.

J Child Adolesc Psychopharmacol. 2011 Aug;21(4):345-51. doi: 10.1089/cap.2010.0102. Epub 2011 Aug 8.

PMID:
21823912
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms.

Macfadden W, Adler CM, Turkoz I, Haskins JT, Turner N, Alphs L.

BMC Psychiatry. 2011 Oct 28;11:171. doi: 10.1186/1471-244X-11-171.

PMID:
22034906
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.

Juruena MF, Ottoni GL, Machado-Vieira R, Carneiro RM, Weingarthner N, Marquardt AR, Fleig SS, Broilo L, Busnello EA.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):94-9. doi: 10.1016/j.pnpbp.2008.10.012. Epub 2008 Oct 31.

PMID:
19007842
[PubMed - indexed for MEDLINE]
19.

Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.

Sachs G, Sanchez R, Marcus R, Stock E, McQuade R, Carson W, Abou-Gharbia N, Impellizzeri C, Kaplita S, Rollin L, Iwamoto T; Aripiprazole Study Group.

J Psychopharmacol. 2006 Jul;20(4):536-46. Epub 2006 Jan 9.

PMID:
16401666
[PubMed - indexed for MEDLINE]
20.

Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.

Tramontina S, Zeni CP, Ketzer CR, Pheula GF, Narvaez J, Rohde LA.

J Clin Psychiatry. 2009 Apr 21;70(5):756-64. doi: 10.4088/JCP.08m04726.

PMID:
19389329
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk